Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART: Melatonin for Pediatric Epilepsy
NCT05439876Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in sleep disorder, sponsored by National Taiwan University Hospital. Started Jul 2022; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT05439876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05439876.